Based on its role in promoting a more potent and persistent memory T cell phenotype, it is predicted that CAR-T cells manufactured with interleukin-15 would exhibit increased release of effector cytokines (such as IFN-γ and TNF-α) upon antigen stimulation compared to CAR-T cells manufactured without it.